Femasys (FEMY) Net Cash Flow Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -342.50% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 131.47% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -40.20% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -194.15% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 460.71% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 84.02% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 144.81% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -62.65% |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | -1,153.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,153.15% |
| Dec 31, 2025 | 212.93% |
| Sep 30, 2025 | 122.84% |
| Jun 30, 2025 | 86.03% |
| Mar 31, 2025 | 109.50% |
| Dec 31, 2024 | -131.94% |
| Sep 30, 2024 | -193.89% |
| Jun 30, 2024 | -892.76% |
| Mar 31, 2024 | -38.55% |
| Dec 31, 2023 | 527.89% |
| Sep 30, 2023 | 35.30% |
| Jun 30, 2023 | 120.51% |
| Mar 31, 2023 | 7.12% |
| Dec 31, 2022 | -21.88% |
| Sep 30, 2022 | -20.64% |
| Jun 30, 2022 | -109.52% |
| Mar 31, 2022 | -130.95% |
| Dec 31, 2021 | -100.78% |
| Sep 30, 2021 | -191.57% |